PB2317: POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB THERAPY IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-INSTITUTION EXPERIENCE FOCUSING ON DETAILED ASSESSMENT OF TOXICITIES
Mitsuhito Hirano,
Kikuaki Yoshida,
Kei Hirano,
Yukako Teramoto,
Mikako Tamba,
Nobuhiko Yamauchi,
Yuko Shirouchi,
Yuko Ishihara,
Hiroaki Asai,
Yuko Mishima,
Kengo Takeuchi,
Dai Maruyama
Affiliations
Mitsuhito Hirano
1 Japanese Foundation for Cancer Research, Department of Hematology Oncology, Koto City, Japan
Kikuaki Yoshida
1 Japanese Foundation for Cancer Research, Department of Hematology Oncology, Koto City, Japan
Kei Hirano
1 Japanese Foundation for Cancer Research, Department of Hematology Oncology, Koto City, Japan
Yukako Teramoto
1 Japanese Foundation for Cancer Research, Department of Hematology Oncology, Koto City, Japan
Mikako Tamba
1 Japanese Foundation for Cancer Research, Department of Hematology Oncology, Koto City, Japan
Nobuhiko Yamauchi
1 Japanese Foundation for Cancer Research, Department of Hematology Oncology, Koto City, Japan
Yuko Shirouchi
1 Japanese Foundation for Cancer Research, Department of Hematology Oncology, Koto City, Japan
Yuko Ishihara
1 Japanese Foundation for Cancer Research, Department of Hematology Oncology, Koto City, Japan
Hiroaki Asai
1 Japanese Foundation for Cancer Research, Department of Hematology Oncology, Koto City, Japan
Yuko Mishima
1 Japanese Foundation for Cancer Research, Department of Hematology Oncology, Koto City, Japan
Kengo Takeuchi
2 Japanese Foundation for Cancer Research, Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Koto City, Japan
Dai Maruyama
1 Japanese Foundation for Cancer Research, Department of Hematology Oncology, Koto City, Japan
